CARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers

Doxorubicin and Cisplatin are the frontline therapeutics for treatment of the triple negative breast cancers (TNBCs). Emergence of drug-resistance often contributes to failure of drugs and poor prognosis, and thus necessitates development of new and improved modalities to treat TNBCs. We generated a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheriyan, Vino T., Muthu, Magesh, Patel, Ketan, Sekhar, Sreeja, Rajeswaran, Walajapet, Larsen, Scott D., Polin, Lisa, Levi, Edi, Singh, Mandip, Rishi, Arun K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341985/
https://www.ncbi.nlm.nih.gov/pubmed/27687593
http://dx.doi.org/10.18632/oncotarget.12333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5341985/
https://www.ncbi.nlm.nih.gov/pubmed/27687593
http://dx.doi.org/10.18632/oncotarget.12333

Ejemplares similares